Guangzhou Qianxun Biotechnology Co., Ltd.
Stay informed on Qianxun Bio's latest research achievements and industry updates
Titled "A Century of Zhongkai, Now Bound to Me", Prof. Cong Feng shared his transition from the R&D frontline of enterprises to the university podium, and pledged on behalf of all new faculty: teach well, study well, write papers in the fields and deliver results to the production frontline, greeting the university's centennial in 2027.
Read More
Systematically introducing PDCoV's discovery history, etiological characteristics, clinical symptoms and epidemiology, we officially release the PDCoV S protein expressed in CHO cells — strong antigenicity, high specificity, no cross-reactivity with PEDV/TGEV, suitable for ELISA, colloidal gold, mAb development and vaccine R&D.
Read More
Through "hands-on demonstration and one-on-one guidance", Dean Fan Hengxin systematically taught five core skills — canine/feline restraint, venous blood collection, indwelling needle puncture, injection and clinical microscopy — with real dogs and cats throughout, enabling students to master real clinical skills in the classroom.
Read More
Many pet owners in Guangzhou are looking for reliable, well-reviewed, specialty-matched pet doctors. Whether it's feline eye disease, canine orthopedic fractures, niche exotic-animal care, pet cardiology chronic disease and geriatric management, or high-end CT/MRI imaging, this article compiles trusted specialist resources for you.
Read More
Following the incident of thousands of cats paralyzed, Prof. Cong Feng, a renowned expert in animal infectious disease prevention and control, provided a professional analysis from the perspective of foodborne etiology, pointing out that the cause may be more complex.
Read More
The Ministry of Agriculture and Rural Affairs officially issued the veterinary biological product clinical trial approval. The cat GnRH protein (E. coli-derived) clinical trial project, led by Prof. Cong Feng, relying on the Guangdong Provincial Engineering Technology Research Center for Intelligent Prevention and Control of Aquatic Animal Disease Biosecurity, and jointly declared with Changzhou Fubang Bio-Pharmaceutical Co., Ltd. and Shangqiu Meilan Bio Co., Ltd., was approved.
Read More
Prof. Cong Feng led the team deep into the hatching workshop, precisely testing nearly 5,000 meconium samples from chicks. Its high-throughput testing system once set an industry benchmark of 10,000 tests per day.
Read More
As a core member of the science and technology envoy team, Researcher Cong Feng went deep into the Yingde pigeon industry frontline, offering advice on key issues such as disease prevention and control, and helping rural revitalization.
Read More
We are committed to providing high-quality antigen, antibody and other active raw materials for animal diseases. For the newly developed CSFV-E2 protein mAb product, teachers are welcome to try it and give feedback on its performance.
Read More
30 animal virus mAbs launched: Getah virus, African swine fever, Seneca virus, parainfluenza type 5, avian influenza H9, canine adenovirus, porcine epidemic diarrhea, feline coronavirus, bovine coronavirus, etc. Welcome to purchase.
Read More
Providing the most cost-effective animal MRI and CT scanning services in Guangzhou, supporting pet clinical diagnosis, laboratory animal research imaging and other needs.
Read More
Qianxun Bio has successfully developed 6 FHV mAbs, all reactive with native virus, with excellent performance in indirect immunofluorescence assays, available for research customers.
Read More
Monoclonal antibody products against porcine epidemic diarrhea virus, transmissible gastroenteritis virus, rotavirus and porcine circovirus type 2 are officially launched.
Read More
The company has successfully isolated a feline calicivirus, seeking cooperation in vaccine development, paper research, etc. Welcome to contact us.
Read More
Qianxun Bio expands its polyclonal antibody product line; polyclonal antibodies against COVID-19, classical swine fever, foot-and-mouth disease and others are officially launched.
Read More
The company has successfully isolated a feline herpesvirus (FHV), opening collaboration channels usable for vaccine research, diagnostic reagent development and paper publication.
Read More
Dr. Cong Feng's team was among the first to construct the SARS-CoV-2 N protein expression strain and freely shared it with more than 1,200 research teams worldwide; People's Daily praised it twice.
Read More